A Small-Molecule Protein-Protein Interaction Inhibitor of PARP1 That Targets Its BRCT Domain

Title
A Small-Molecule Protein-Protein Interaction Inhibitor of PARP1 That Targets Its BRCT Domain
Authors
Zhenkun NaBo PengShukie NgSijun Pan이준석Han Ming ShenShao Q. Yao
Keywords
protein protein interaction; mass spectrometry
Issue Date
2015-02
Publisher
Angewandte Chemie international edition
Citation
VOL 127, 2545-2549
Abstract
Poly(ADP-ribose)polymerase-1 (PARP1) is a BRCT-containing enzyme (BRCT=BRCA1 C-terminus) mainly involved in DNA repair and damage response and a validated target for cancer treatment. Small-molecule inhibitors that target the PARP1 catalytic domain have been actively pursued as anticancer drugs, but are potentially problematic owing to a lack of selectivity. Compounds that are capable of disrupting protein–protein interactions of PARP1 provide an alternative by inhibiting its activities with improved selectivity profiles. Herein, by establishing a high-throughput microplatebased assay suitable for screening potential PPI inhibitors of the PARP1 BRCT domain, we have discovered that (!)-gossypol, a natural product with a number of known biological activities, possesses novel PARP1 inhibitory activity both in vitro and in cancer cells and presumably acts through disruption of protein–protein interactions. As the first known cell-permeable small-molecule PPI inhibitor of PAPR1, we further established that (")-gossypol was likely the causative agent of PARP1 inhibition by promoting the formation of a 1:2 compound/PARP1 complex by reversible formation of a covalent imine linkage.
URI
http://pubs.kist.re.kr/handle/201004/49397
ISSN
14337851
Appears in Collections:
KIST Publication > Article
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE